Efficacy and safety of metoprolol in the treatment of doxorubicin-induced cardiomyopathy in pediatric patients

Am Heart J. 1995 Jan;129(1):197-9. doi: 10.1016/0002-8703(95)90061-6.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adolescent
  • Child
  • Doxorubicin / adverse effects*
  • Heart Failure / chemically induced*
  • Heart Failure / diagnosis
  • Heart Failure / drug therapy*
  • Humans
  • Male
  • Metoprolol / therapeutic use*
  • Remission Induction
  • Time Factors

Substances

  • Doxorubicin
  • Metoprolol